David Colcher

Title: The Innovations of David Colcher

Introduction

David Colcher is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of radioprotection, particularly in the development of methods to enhance the stability of radiolabeled peptides. With a total of 2 patents to his name, Colcher's work is recognized for its potential applications in medical and pharmaceutical industries.

Latest Patents

Colcher's latest patents focus on a radioprotectant for peptides labeled with radioisotopes. The first patent describes a method of ameliorating the degradation of radiolabeled peptides, especially proteins such as antibodies, by incorporating povidone, also known as polyvinylpyrrolidone or PVP, as a radioprotectant. This composition aims to stabilize radiolabeled peptides, enhancing their effectiveness. Additionally, the patent outlines a stable peptide-radioisotope composition that includes povidone, with the option to add ascorbic acid or other secondary stabilizers to further improve radioprotection.

Career Highlights

Colcher is currently associated with Coulter Pharmaceutical, Inc., where he continues to innovate in the field of radioprotection. His work has the potential to significantly impact the development of safer and more effective radiolabeled therapies.

Collaborations

Throughout his career, Colcher has collaborated with notable colleagues, including Dan Shochat and Michael J Buckley. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

David Colcher's contributions to the field of radioprotection through his innovative patents demonstrate his commitment to advancing medical science. His work at Coulter Pharmaceutical, Inc. continues to pave the way for future developments in radiolabeled therapies.